Severe sulfonamide hypersensitivity reaction in a slow acetylator patient

Infectious Diseases in Clinical Practice

Volumn 10, Issue 9, 2001, Pages 493-495

  Yap, Richard L ^a   Mermel, Leonard A ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CYTOCHROME P450 2C9; DAPSONE; SALAZOSULFAPYRIDINE; SULFAMETHOXAZOLE; SULFONAMIDE;

ACETYLATOR PHENOTYPE; ACUTE PANCREATITIS; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CROHN DISEASE; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG METABOLISM; FEMALE; HUMAN; PATHOPHYSIOLOGY;

EID: 0035734622     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-200112000-00008     Document Type: Article

References (18)

1. Fifty years of Sulphonamides
2. Hypersensitivity to Sulphonamides - A clue?
3. Diagnosis of Sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites
4. Practical issues in the management of hypersensitivity reactions: Sulfonamides
5. Allergic reactions to antimicrobial agents: A review of reactions to drugs not in the beta lactam antibiotic class
6. Severe adverse cutaneous reactions to drugs
7. Synthesis and in vitro toxicity of hydroxylamine metabolites of Sulfonamides
8. Prominence of slow acetylator phenotype among patients with Sulfonamide hypersensitivity reactions
9. Sulphasalazine for rheumatoid arthritis: Studies on dose, acetylator phenotype and efficacy
10. Predisposing factors in Sulphasalazine-induced systemic lupus erythematosus
11. Arylamine N-acetyltransferase (NAT 2) mutations and their allelic linkage in unrelated caucasian individuals: Correlation with phenotypic activity
12. Idiosyncratic drug reactions: The reactive metabolite syndromes
13. Differences in metabolism of Sulfonamides predisposing to idiosyncratic toxicity
14. In vitro cytotoxicity as a marker of hypersensitivity to Sulphamethoxazole in patients with HIV
15. Toxicity of Sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and noninfected cells
16. Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients
17. Treatment of severe drug eruptions
18. A randomized trial of N-acetylcysteine for prevention of Trimethoprim-Sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057)